The Discontinuation of Kaplan-Meier Curves report plots the number of subjects still enrolled in the study versus days completed.
Running this report for Nicardipine using default settings generates the tabbed Results window shown below.
The Report window contains the following:
|
•
|
Data Filter: This enables you to subset subjects based on demographic characteristics and other criteria. Refer to Data Filter for more information.
|
|
•
|
Results (Discontinuation Time to Event): This tab contains a Kaplan-Meier time-to-event analysis as well as a contingency analysis of treatment versus discontinuation status. You can define what constitutes a discontinuation using the Define events as: option in the dialog.
|
|
•
|
Profile Subjects: Select subjects and click
 to generate the patient profiles for subjects experiencing selected events. See Profile Subjects for additional information. |
|
•
|
Show Subjects: Select subjects and click
 to open the ADSL (or DM if ADSL is unavailable) of selected subjects for subjects experiencing selected events. |
|
•
|
Cluster Subjects: Select subjects and click
 to cluster subjects experiencing selected events based on available covariates. See Cluster Subjects for additional information. |
|
•
|
Demographic Counts: Select subjects and click
 to create a data set of USUBJIDs for subjects experiencing selected events, which subsets all subsequently run reports to those selected subjects. |
|
•
|
Click
 to view the associated data tables. Refer to View Data for more information. |
|
•
|
Click
 to generate a standardized pdf- or rtf-formatted report containing the plots and charts of selected sections. |
|
•
|
Click
 to take notes, and store them in a central location. Refer to Add Notes for more information. |
|
•
|
Click
 to read user-generated notes. Refer to View Notes for more information. |
|
•
|
Click the arrow to reopen the completed dialog used to generate this output.
|
|
•
|
Click the gray border to the left of the Options tab to open a dynamic report navigator that lists all of the reports in the review. Refer to Report Navigator for more information.
|